Elizabeth Burtally's blog posts
What’s been happening at the European Hematology Association Congress 2018
One of the biggest haematology events of the year has kicked off in Stockholm. Highlights so far include new research on CAR-T therapy and folllicular lymphoma
RUNX genes and their role in blood cancer development
Professor James Neil – one of our researchers at The University of Glasgow – sheds light on how we may be able to reverse resistance to commonly used drugs in blood cancer treatment.
New Years Honours 2017 – leading Bloodwise scientists recognised in list
The Queen’s New Year’s Honours List recognises the achievements and service of extraordinary people across the United Kingdom. We were delighted to see some of our Bloodwise funded researchers on the list – find out more here.
New exciting Bloodwise research published
Find out more about some of the very latest Bloodwise research news.
Leukaemia and the value of junk DNA
Find out how a hotspot in ‘junk’ DNA appears to be controlling how a nearby cancer-causing gene behaves.
Finding the right drug combination for chronic lymphocytic leukaemia patients
Professor Mark Cragg is searching for clues to how some current cancer drugs work, so we can identify the ideal drug combinations that deliver the best benefits for patients. Find out more about this exciting research here.